Lyfebulb Announces Finalists for the 2022 Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease
/PRNewswire/ -- Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation, education and connectivity, is...
Source: prnewswire.com